ATC Group: S01XA27 Voretigene neparvovec

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of S01XA27 in the ATC hierarchy

Level Code Title
1 S Sensory organs
2 S01 Ophthalmologicals
3 S01X Other ophthalmologicals
4 S01XA Other ophthalmologicals
5 S01XA27

Active ingredients in S01XA27

Active Ingredient

Voretigene neparvovec results to transduction of retinal pigment epithelial cells with a cDNA encoding normal human RPE65 protein (gene augmentation therapy), providing the potential to restore the visual cycle in patients with vision loss due to inherited retinal dystrophy.

Related product monographs

Document Type Information Source  
 LUXTURNA Concentrate and solvent for solution for injection MPI, EU: SmPC European Medicines Agency (EU)

Medicines classified under this ATC code globally

Austria (AT)

Brazil (BR)

Croatia (HR)

Estonia (EE)

France (FR)

Ireland (IE)

Israel (IL)

Italy (IT)

Lithuania (LT)

Netherlands (NL)

Poland (PL)

Romania (RO)

Spain (ES)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.